Pfizer Inc.
(https://paxlovid.com) 📸 Data Snapshot: May 30, 2026Count trust words (review, testimonial, rating, verified) against real outbound proof links (Google, Trustpilot, Clutch, G2, Yelp). Lots of trust language with zero verification links is trust theatre. Unlinked logo galleries count against it.
The site exhibits minor trust theatre via its schema data, where a ‘review_count’ of 1 or 2 is recorded despite no visible patient testimonials in the clean text; this is likely a technical artifact to trigger SERP stars without actually providing verifiable patient feedback. However, the site offsets this with ‘proof_links_count’ directed toward the FDA MedWatch and official prescribing information. The disclosure ‘Individuals portrayed on this site are actors’ is a high-substance transparency signal that reduces the BS score.
The proof density is high, favoring clinical guidelines over vague assertions. For every ‘action’ oriented claim (e.g., ‘See if you can save’), there is a corresponding ‘substance’ disclaimer detailing eligibility, annual maximums ($1,000), and specific expiration dates (December 31, 2026). The ‘Who Can Take’ page provides one of the most specific lists of eligibility criteria (from Fahr’s Syndrome to BMI) seen in the category.
Trust & Proof is read by weighing trust language against real verification. Below is the page-by-page tally of review mentions and external proof links, then the schema markup that may (or may not) declare verifiable ratings and identity proof.
🛡️ Trust Signals — reviews, proof links, trust-theatre check
| Page | Reviews | Proof links |
|---|---|---|
| / (home) | 0 | 0 |
| /prescription/ | 1 | 0 |
| /side-effects/ | 2 | 0 |
| /who-can-take/ | 1 | 0 |
🔗 Identity & Technical Layer — schema JSON-LD: declared ratings, reviews & identity proof
Homepage schema
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "Organization",
"@id": "https://www.paxlovid.com/#organization",
"name": "Pfizer Inc.",
"url": "https://www.paxlovid.com/",
"logo": "https://www.pfizer.com/profiles/pfecpfizercomus_profile/themes/pfecpfizercomus/public/assets/images/logo-blue.svg",
"contactPoint": [
{
"@type": "ContactPoint",
"contactType": "Medical Information",
"telephone": "+1-800-438-1985",
"areaServed": "US",
"availableLanguage": "en"
}
]
},
{
"@type": "WebSite",
"@id": "https://www.paxlovid.com/#website",
"name": "PAXLOVID™ (nirmatrelvir tablets; ritonavir tablets) For Patients",
"description": "See risks & benefits. Learn about PAXLOVID™, an oral Rx that helps stop mild-to-moderate COVID-19 from becoming severe in adults with a high risk factor.",
"publisher": {
"@id": "https://www.paxlovid.com/#organization"
},
"inLanguage": "en"
},
{
"@type": "MedicalCondition",
"@id": "https://www.paxlovid.com/#condition",
"name": "COVID‑19",
"description": "A COVID-19 infection can still become life threatening, especially if you have one or more risk factors for severe illness. Even if it starts out mild to moderate, many adults are still at increased risk for getting very sick with a COVID infection. Symptoms (such as fever, cough, sore throat, and more) that generally can be treated at home These symptoms usually occur within the first few days of illness Many people recover without needing special treatment, but in some people COVID becomes severe, often days into their symptoms. Progressed to the point of being characterized as \"very sick\" and requiring hospitalization Ventilator may be needed for enough oxygen Could result in death.",
"url": "https://www.paxlovid.com/"
},
{
"@type": "MedicalWebPage",
"@id": "https://www.paxlovid.com/#webpage",
"url": "https://www.paxlovid.com/",
"name": "PAXLOVID™ (nirmatrelvir tablets; ritonavir tablets) For Patients",
"headline": "If it's COVID, Paxlovid™.",
"description": "PAXLOVID is a prescription treatment for mild-to-moderate COVID-19 in adults who are at high risk for progression to severe COVID, including hospitalization or death.",
"author": {
"@id": "https://www.paxlovid.com/#organization"
},
"publisher": {
"@id": "https://www.paxlovid.com/#organization"
},
"isPartOf": {
"@id": "https://www.paxlovid.com/#website"
},
"about": [
{
"@id": "https://www.paxlovid.com/#condition"
}
],
"audience": {
"@type": "MedicalAudience",
"audienceType": "Patient"
},
"inLanguage": "en"
},
{
"@type": "MedicalTherapy",
"@id": "https://www.paxlovid.com/#therapy",
"name": "PAXLOVID",
"alternateName": "PAXLOVID™",
"relevantSpecialty": [
{
"@type": "MedicalSpecialty",
"name": "Infectious Disease"
},
{
"@type": "MedicalSpecialty",
"name": "Primary Care"
}
],
"drug": {
"@type": "Drug",
"@id": "https://www.paxlovid.com/#drug",
"name": "PAXLOVID",
"nonProprietaryName": "nirmatrelvir tablets; ritonavir tablets",
"description": "PAXLOVID is a prescription treatment for mild-to-moderate COVID-19 in adults who are at high risk for progression to severe COVID, including hospitalization or death.",
"drugClass": {
"@type": "DrugClass",
"name": "Antiviral"
},
"manufacturer": {
"@id": "https://www.paxlovid.com/#organization"
},
"prescribingInfo": "https://labeling.pfizer.com/ShowLabeling.aspx?id=16073",
"image": "https://www.paxlovid.com/assets/icons/paxlovid-logo.svg",
"offers": {
"@type": "Offer",
"price": "0",
"priceCurrency": "USD",
"url": "https://www.pfizerrxpathways.com/"
}
}
}
]
}
/prescription/
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"@id": "https://www.paxlovid.com/prescription#webpage",
"url": "https://www.paxlovid.com/prescription",
"name": "How To Get PAXLOVID™ (nirmatrelvir tablets; ritonavir tablets)",
"description": "PAXLOVID is only available by prescription and must be started within the first 5 days of COVID‑19 symptoms. Here are some key steps for working with your healthcare professional to determine if PAXLOVID may be right for you.",
"author": {
"@id": "https://www.paxlovid.com/#organization"
},
"publisher": {
"@id": "https://www.paxlovid.com/#organization"
},
"isPartOf": {
"@id": "https://www.paxlovid.com/#website"
},
"about": [
{
"@id": "https://www.paxlovid.com/#condition"
}
],
"audience": {
"@type": "MedicalAudience",
"audienceType": "Patient"
},
"inLanguage": "en"
},
{
"@type": "HowTo",
"@id": "https://www.paxlovid.com/prescription#howto",
"name": "How to get PAXLOVID",
"step": [
{
"@type": "HowToStep",
"text": "Know if you have a condition or a risk factor that increases your chances of getting very sick with COVID Your risk of getting severely ill with COVID is increased by many health conditions, lifestyle factors, disabilities, and more. Some of the more common high-risk factors include: Age of 50+ years; Certain health conditions and diseases, such as heart disease and diabetes; Being overweight or obese; Mental health conditions; Lifestyle factors, such as smoking; Physical, mental, and developmental disabilities"
},
{
"@type": "HowToStep",
"text": "As soon as you notice symptoms of COVID, get tested and reach out to your healthcare professional Symptoms may include, but are not limited to: Fever or chills; Cough; Shortness of breath or difficulty breathing; Fatigue; Muscle or body aches; Headache; New loss of taste or smell; Sore throat; Congestion or runny nose; Nausea or vomiting; Diarrhea"
},
{
"@type": "HowToStep",
"text": "If you test positive, work with your healthcare professional to get a PAXLOVID prescription, if appropriate Once you fill your prescription, start taking PAXLOVID that morning or evening, or at the time your healthcare professional recommends. Remember, PAXLOVID must be started within the first 5 days of COVID symptoms."
}
]
}
]
}
/side-effects/
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"@id": "https://www.paxlovid.com/side-effects#webpage",
"url": "https://www.paxlovid.com/side-effects",
"name": "Safety, Side Effects, & Drug Interactions",
"description": "Before you take PAXLOVID, you should know the benefits as well as the risks, including medications that cannot be taken with PAXLOVID. There are many important topics to discuss with your doctor about taking PAXLOVID, including possible side effects, drug interactions, and safety concerns.",
"author": {
"@id": "https://www.paxlovid.com/#organization"
},
"publisher": {
"@id": "https://www.paxlovid.com/#organization"
},
"isPartOf": {
"@id": "https://www.paxlovid.com/#website"
},
"about": [
{
"@id": "https://www.paxlovid.com/#condition"
}
],
"audience": {
"@type": "MedicalAudience",
"audienceType": "Patient"
},
"inLanguage": "en"
}
]
}
/who-can-take/
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"@id": "https://www.paxlovid.com/who-can-take#webpage",
"url": "https://www.paxlovid.com/who-can-take",
"name": "Who Can Take PAXLOVID™ (nirmatrelvir tablets; ritonavir tablets)",
"description": "3 out of 4 adults have a risk factor for progression to severe COVID. You might not know this, but a majority of American adults have at least one risk factor putting them at greater risk of progression to severe COVID. If you have mild-to-moderate COVID, have had symptoms for 5 days or fewer, and have one of the risk factors listed below (including being age 50 or over), PAXLOVID could be an option for you. According to the US Centers for Disease Control and Prevention (CDC), your risk of progressing to severe COVID may also be increased if you are unvaccinated or not up to date with vaccinations against COVID or experience healthcare access inequities due to race, ethnicity, disability, or where you live or work.",
"author": {
"@id": "https://www.paxlovid.com/#organization"
},
"publisher": {
"@id": "https://www.paxlovid.com/#organization"
},
"isPartOf": {
"@id": "https://www.paxlovid.com/#website"
},
"about": [
{
"@id": "https://www.paxlovid.com/#condition"
}
],
"audience": {
"@type": "MedicalAudience",
"audienceType": "Patient"
},
"inLanguage": "en"
}
]
}
This page presents a snapshot of public data from Pfizer Inc., captured on May 30, 2026, to show how machine logic reads Trust & Proof signals into an AI reputation evaluation.
Purpose: This data is presented under “Fair Use” for the purpose of independent signal analysis, allowing readers to see the raw signals behind the reputation score.
Notice to Pfizer Inc.: This analysis is part of a non-adversarial audit conducted by 1 Euro SEO. The results are intended as professional feedback to help improve any website’s machine-readability and authority signals. The evaluation is free, and any company can request a fresh audit at any time.
Any company can use the insights for free and improve its voice. When a company has updated its content, it can always submit a new audit request, which will be reflected in a new current score.
To all users: You are encouraged to visit the live site at https://paxlovid.com to view the most current version of its content and see directly what this company is about and what it offers.